Standardized RNA extraction protocol for Entamoeba species: advancing molecular diagnostics and amebiasis control
Frontiers in Cellular and Infection Microbiology · 29.05.2026 · 16
DOI: 10.3389/fcimb.2026.1797458 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 29.05.2026. Verfasst von Gabriele Cox und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Genomics and Bioinnovations, Oswaldo Cruz Institute, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Entamoeba, RNA, Protozoan, Molecular Diagnostic Techniques, Entamoebiasis. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amebiasis, caused by Entamoeba histolytica , remains a major public health challenge in endemic regions and is often misdiagnosed due to its morphological similarity to the non-pathogenic species E. dispar . The limitations of light microscopy and the high cost of immunological assays. This study aimed to standardize RNA extraction methods in Entamoeba to support high-quality transcriptomic analyses and molecular investigations Six RNA extraction protocols were compared using E. histolytica and E. dispar trophozoites, and RNA yield, purity, and integrity were assessed by spectrophotometry (NanoDrop), fluorometry (Qubit), and automated electrophoresis (TapeStation). The TRIzol + RNeasy protocol provided the highest purity ratios (260/280 and 260/230) and was selected as the standard method. Extracted RNA showed good integrity (RINe 7.2 for E. histolytica and 6.6 for E. dispar ), supporting RNA-Seq library construction. Two library preparation strategies were evaluated: poly(A) selection and ribosomal RNA (rRNA) depletion. Both generated libraries with appropriate profiles; however, poly(A) selection was more efficient, yielding higher RNA concentrations and low residual rRNA (<3.5%), whereas rRNA depletion remained inefficient (~87% rRNA). This standardized RNA extraction workflow combined with poly(A) selection represents an effective strategy for transcriptomic analyses in Entamoeba , providing a robust methodological foundation to advance transcriptomic studies, biomarker discovery, and a deeper understanding of Entamoeba biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Applied Genomics and Bioinnovations, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
- Laboratory of Molecular Diagnosis and Hematology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
- Next-Generation Sequencing Platform - RPT01J, Fiocruz Technological Platforms Network (RPT), Vice Presidency of Research and Biological Collections (VPPCB), Rio de Janeiro, Brazil.
- Bioinformatics Platform - RPT04A (VPPCB), Rio de Janeiro, Brazil.
Zitieren
APA
Cox, G., Melo, M., Andrade, A., Müller, B., Dos Santos, A., Moreira, A. D. S., de Araujo, N. S., Moreira, D., Parente, T., Degrave, W., Toma, H., & Waghabi, M. (2026). Standardized RNA extraction protocol for Entamoeba species: advancing molecular diagnostics and amebiasis control. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1797458
Vancouver
Cox G, Melo M, Andrade A, Müller B, Dos Santos A, Moreira ADS, et al. Standardized RNA extraction protocol for Entamoeba species: advancing molecular diagnostics and amebiasis control. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1797458
BibTeX
@article{Cox2026,
author = {Cox, Gabriele and Melo, Marília and Andrade, Audrien and Müller, Beatriz and Dos Santos, Alexandre and Moreira, Aline Dos Santos and de Araujo, Natassia Silva and Moreira, Daniel and Parente, Thiago and Degrave, Wim and Toma, Helena and Waghabi, Mariana},
title = {Standardized RNA extraction protocol for Entamoeba species: advancing molecular diagnostics and amebiasis control},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1797458}
}
EUVIMED